The odds ratio for AIS/invasive adenocarcinoma was 4.092, and 95% CI was from 1.424 to 11.753, suggesting significant correlation between the expression of E2A-PBX1 fusion transcripts and patients with AIS. The gene discussed is PBX1; the disease is androgen insensitivity syndrome.